Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Silexion Therapeutics Corp market cap is $850,882.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Silexion Therapeutics Corp 52 week high is $777.12 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Silexion Therapeutics Corp 52 week low is $1.26 as of November 22, 2026.
Silexion Therapeutics Corp stock price today is $1.31.
Silexion Therapeutics Corp stock price yesterday was $1.50.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Silexion Therapeutics Corp's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Silexion Therapeutics Corp P/B ratio is 0.2662.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Silexion Therapeutics Corp 50-day moving average is $4.97.